Skip to main content

Sweeny Nicole

In the past year, 5 open-market sale filings worth $240.5K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$240.5K
5 filings
Net
−$240.5K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Sweeny Nicole as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

KALV KalVista Pharmaceuticals, Inc.

Chief Commercial Officer7 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 27, 2026 (view filing)May 261 daySweeny NicoleChief Commercial OfficerSSale−1.49K$26.78−$39.9K−2.4%59.3K after
May 26, 2026 (view filing)May 224 daysSweeny NicoleChief Commercial OfficerSSale−1.86K$26.78−$49.8K−3.2%55.8K after
Apr 20, 2026 (view filing)Apr 173 daysSweeny NicoleChief Commercial OfficerSSale−1.86K$20.22−$37.6K−3.5%51.4K after
Feb 24, 2026 (view filing)Feb 231 daySweeny NicoleChief Commercial OfficerSSale−3.98K$15.57−$61.9K−7.8%47.0K after
Dec 4, 2025 (view filing)Nov 2410 daysLateSweeny NicoleChief Commercial OfficerSSale−3.81K$13.45−$51.3K−8.8%39.7K after
Aug 26, 2025 (view filing)Aug 251 daySweeny NicoleChief Commercial OfficerSSale−1.48K$13.42−$19.9K−4.4%32.3K after
Aug 25, 2025 (view filing)Aug 223 daysSweeny NicoleChief Commercial OfficerSSale−1.86K$13.22−$24.6K−6.1%28.8K after